Almost half of 9 and 10-year-olds get HPV vaccination at first opportunity
This spring, more than 800,000 young people received an invitation to be vaccinated against HPV, the human papillomavirus.
RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine
State Secretary Blokhuis: boys will also be vaccinated against HPV virus
The vaccine against the HPV human papillomavirus virus will also become available for boys.
Research: HPV vaccine is safe
RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.
Vaccination rate again drops slightly, HPV vaccination rate drops considerably
The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.
RIVM and Olive Foundation open trading to mark the European Cervical Cancer Prevention Week
January 20th, the Olive Foundation and RIVM opened AEX trading day in Amsterdam on the occasion of the 9th European Cervical Cancer Prevention Week.
The National Immunisation Programme in the Netherlands 2013 - 2014
Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).
Increasing number of girls immunised against HPV
In 2014 the number of girls who were immunised against the human papilloma virus (HPV) rose. This virus can cause cervical cancer later in life.